Diagnosis and treatment of Graves diseaseSTREETMAN, Darcie D; KHANDERIA, Ujjaini.The Annals of pharmacotherapy. 2003, Vol 37, Num 7-8, pp 1100-1109, issn 1060-0280, 10 p.Article

Effect of β-adrenoceptor antagonist and angiotensin-converting enzyme inhibitor on hypertension-associated changes in Adenylyl cyclase type V messenger RNA expression in spontaneously hypertensive ratsFUJINO, Takayuki; HASEBE, Naoyuki; KAWABE, Jun-Ichi et al.Journal of cardiovascular pharmacology. 2003, Vol 41, Num 5, pp 720-725, issn 0160-2446, 6 p.Article

Chiral chromatographic separation of β-blockersAGRAWAL, Y. K; PATEL, R. N.Journal of chromatography. B. 2005, Vol 820, Num 1, pp 23-31, issn 1570-0232, 9 p.Article

Long-term treatment with the β-blocker carvedilol restores autonomic tone and responsiveness in patients with moderate heart failureMALFATTO, Gabriella; FACCHINI, Mario; BRANZI, Giovanna et al.Journal of cardiovascular pharmacology. 2003, Vol 42, Num 1, pp 125-131, issn 0160-2446, 7 p.Article

Ligand-directed signalling at β-adrenoceptors : Molecular pharmacology of G protein-coupled receptorsEVANS, Bronwyn A; SATO, Masaaki; SARWAR, Mohsin et al.British journal of pharmacology. 2010, Vol 159, Num 5, pp 1022-1038, issn 0007-1188, 17 p.Article

Resistant hypertension in patients with chronic aortic dissectionEGGEBRECHT, H; SCHMERMUND, A; VON BIRGELEN, C et al.Journal of human hypertension. 2005, Vol 19, Num 3, pp 227-231, issn 0950-9240, 5 p.Article

Fluvial biofilms: A pertinent tool to assess β-blockers toxicityBONNINEAU, Chloé; GUASCH, Helena; PROIA, Lorenzo et al.Aquatic toxicology. 2010, Vol 96, Num 3, pp 225-233, issn 0166-445X, 9 p.Article

β₁-Adrenergic receptor polymorphisms and left ventricular remodeling changes in response to β-blocker therapyTERRA, Steven G; HAMILTON, Karen K; YARANDI, Hossein N et al.Pharmacogenetics (London). 2005, Vol 15, Num 4, pp 227-234, issn 0960-314X, 8 p.Article

Β₁-Adrenergic receptor polymorphisms and left ventricular remodeling changes in response to β-blocker therapyTERRA, Steven G; HAMILTON, Karen K; YARANDI, Hossein N et al.Pharmacogenetics and genomics (Print). 2005, Vol 15, Num 4, pp 227-234, issn 1744-6872, 8 p.Article

Palatability of crushed β―blockers, converting enzyme inhibitors and thiazidesZGRAGGEN, L; FARE, P. B; LAVA, S. A. G et al.Journal of clinical pharmacy and therapeutics (Print). 2012, Vol 37, Num 5, pp 544-546, issn 0269-4727, 3 p.Article

Use of β-Blockers in Patients with an Implantable Cardioverter DefibrillatorLAPOINTE, Nancy M.allen; STAFFORD, Judith A; PAPPAS, Paul A et al.The Annals of pharmacotherapy. 2009, Vol 43, Num 7-8, pp 1189-1196, issn 1060-0280, 8 p.Article

Preclinical profile of PF9404C, a nitric oxide donor with β receptor blocking propertiesVILLARROYA, Mercedes; LOPEZ, Manuela G; DE PASCUAL, Ricardo et al.Cardiovascular drug reviews (Print). 2005, Vol 23, Num 2, pp 149-160, issn 0897-5957, 12 p.Article

Detrimental effects of β-blockers in COPD : A concern for nonselective β-blockersVAN DER WOUDE, Hanneke J; ZAAGSMA, Johan; POSTMA, Dirkje S et al.Chest. 2005, Vol 127, Num 3, pp 818-824, issn 0012-3692, 7 p.Article

Dissociating response systems: Erasing fear from memorySOETER, Marieke; KIND, Merel.Neurobiology of learning and memory (Print). 2010, Vol 94, Num 1, pp 30-41, issn 1074-7427, 12 p.Article

Female sexual dysfunction in essential hypertension : a common problem being uncoveredDOUMAS, Michael; TSIODRAS, Sotirios; TSAKIRIS, Alexandros et al.Journal of hypertension. 2006, Vol 24, Num 12, pp 2387-2392, issn 0263-6352, 6 p.Article

Quantitative analysis of β-blockers in pharmaceutical preparations by capillary electrophoresisCORAGEM BRIGUENTI, Ana Cecilia; BONATO, Pierina Sueli.Drug development and industrial pharmacy. 2005, Vol 31, Num 2, pp 209-214, issn 0363-9045, 6 p.Article

Hematopoietic Progenitor Cell Mobilization Is Mediated Through β-2 and β-3 Receptors After Injury. DiscussionBEIERMEISTER, Keith A; KECK, Brett M; SIFRI, Ziad C et al.The Journal of trauma, injury, infection, and critical care. 2010, Vol 69, Num 2, pp 338-343, issn 1079-6061, 6 p.Article

Ivabradine reduces heart rate while preserving metabolic fluxes and energy status of healthy normoxic working heartsLAUZIER, Benjamin; VAILLANT, Fanny; GELINAS, Roselle et al.American journal of physiology. Heart and circulatory physiology. 2011, Vol 69, Num 3, issn 0363-6135, H845-H852Article

Current trends in neurotrauma careTIMMONS, Shelly D.Critical care medicine. 2010, Vol 38, Num 9, issn 0090-3493, S431-S444, SUPArticle

What are the main challenges of heart rate―reducing therapy in heart failure?KOMAJDA, Michel.Dialogues in cardiovascular medicine. 2011, Vol 16, Num 2, pp 101-105, issn 1272-9949, 5 p.Article

β-Blocker in Post-Myocardial Infarct Survivors with Preserved Left Ventricular Systolic FunctionSIU, Chung-Wah; PONG, Vincent; JIM, Man-Hong et al.Pacing and clinical electrophysiology. 2010, Vol 33, Num 6, pp 675-680, issn 0147-8389, 6 p.Article

The role of the new β-blockers in treating cardiovascular diseaseWEBER, Michael A.American journal of hypertension. 2005, Vol 18, Num 12, issn 0895-7061, 169S-176S, 2Article

Simultaneous detection of residues of β-adrenergic receptor blockers and sedatives in animal tissues by high-performance liquid chromatography/tandem mass spectrometryJING ZHANG; BING SHAO; JIE YIN et al.Journal of chromatography. B. 2009, Vol 877, Num 20-21, pp 1915-1922, issn 1570-0232, 8 p.Article

Outcomes of Perioperative β-Blockade in Patients Undergoing Noncardiac Surgery: A Meta-AnalysisTALATI, Ripple; REINHART, Kurt M; WHITE, C. Michael et al.The Annals of pharmacotherapy. 2009, Vol 43, Num 7-8, pp 1181-1188, issn 1060-0280, 8 p.Article

The selectivity of β-adrenoceptor antagonists at the human β1, β2 and β3 adrenoceptorsBAKER, Jillian G.British journal of pharmacology. 2005, Vol 144, Num 3, pp 317-322, issn 0007-1188, 6 p.Article